New research highlights the cost-effectiveness and safety of new weight loss medications alongside bariatric ... by the U.S. Food and Drug Administration (FDA) for weight loss in patients with ...
As a practicing bariatric surgeon at Brigham and Women’s Hospital in Boston, he had noticed an uptick in last-minute cancellations, especially among patients who had recently started taking GLP ...
Roche (RHHBY) announced that the VENTANA CLDN18 RxDx Assay is the first U.S. Food and Drug Administration approved immunohistochemistry companion diagnostic for determining CLDN18 protein expression ...